聯泰控股(00311.HK)上半年純利大增693.11%至759.8萬美元 中期息0.22美仙
格隆匯8月26日丨聯泰控股(00311.HK)發佈公吿,截至2022年6月30日止6個月,公司收益4.63億美元,同比增長38.48%;公司擁有人應占溢利759.8萬美元,同比增長693.11%;每股盈利0.73美仙,派付中期股息每股0.220美仙。
集團的毛利亦由4941.1萬美元大增約54.0%至7607.5萬美元,與集團銷售表現及毛利率的改善情況一致。毛利率由截至2021年6月30日止六個月的14.8%上升至16.4%,主要源於服飾配件分部的分類收入大幅增加,且其毛利率亦較成衣業務高。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.